<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=791414221315877&amp;ev=PageView&amp;noscript=1">

Med-X, Inc. Management Team Signs $86 Million Dollar Non-Binding Term Sheet to Bolster Long Term Growth and Prepare the Company for a Potential Public Listing


Nick Phillips
Posted by Nick Phillips on May 21, 2021 12:15:23 PM

In this exciting Company update, COO and President, Matthew Mills informs shareholders on the status of several international deals, status of ecommerce growth, capital raising and announces an exciting signing of the Company's first non-binding Term Sheet with an investment bank for an 86 Million dollar equity drawdown, to support the Company’s growth initiatives, if and when the Company lists on a public exchange. 


Growth in our digital ecommerce sales efforts continues its pace forward. New initiatives have recently been executed to continue to bolster B2C sales including the approval from Walmart Marketplace to enter the Walmart Fulfillment program. 

Walmart is very selective when it comes to approving brands and companies to be included in this program, so we feel very confident that our products and customer service is making a difference in our customers' lives. Walmart is recognizing us, which is great news for our brands.  

Walmart advertises to its fulfillment partners that customers should expect a 20% to 40% increase in sales by simply entering the program. We will keep you updated on this front in future updates as our team continues to dial this all in. 

Progress also continues to be made on our international Nature-Cide positioning as the labels are currently under review to get approved by the Mexican and Australian governmental authorities. Products have already shipped to Terminix in the Caribbean and Antigua. The compliance and approval processes are critical for our growth internationally but our partners have a solid track record of bringing in new products, and we feel really good about the coming months as we continue to push through the red tape. 

Matthew continues to speak with dozens of interested investment entities including VC’s, Angel investors, Family Offices and Investment Banks. Our partners at New Chip as well as our new broker-dealer, The Dalmore Group, have been actively making strong recommendations and introductions as the management team works tirelessly to find the right fit to assist our efforts to potentially take the Company to the public market. 

Matthew has also initially agreed to an 86 Million dollar non-binding term sheet with a large investment bank who is committed to seeing our Company grow and bolster revenue once the Company is listed.

At this point, the Company fits all the criteria to list on the Nasdaq except for one item. We need an additional $4 million dollars in the bank to fully qualify. Many of our Accredited investors have recognized this opportunity and they have stepped up in a big way to support this mission. 

This money is required so the Company can bridge the gap from private to public, as Matthew explains in the video.

“We are finally in a position where our business is of interest to the investment banking community, and we will continue pushing to line up the right partners. One thing we have learned over the years is to have as many irons in the fire as possible on all fronts. It’s inevitable that some of the relationships will flourish, and others will fizzle and not perform as expected. So, the only way we can move forward is to build an abundance of relationships amongst all of the inner workings of our business, until we find all the right performers,” states Matthew.    

We are hopeful that all of our shareholders will also recognize this opportunity and spread the word by telling their friends, family and co-workers about our Company and how they can also get involved and get in on the ground floor before we potentially file for a listing on a public exchange. 

As Matthew also says in the video, this is an exciting time and all of your support and the hard work from our team has really set the Company up for success and is setting a path for our goals. We would never be in this position without all the support from each and every one of our shareholders. 

We thank you. We are all so grateful to have such an amazing group of people connected to this Company who support all of our work. 

Also, please double-check your investor dashboard to make sure everything is matching up with your records. As we get closer to our end goal it will be critical that your contact information and investment information is accurate. Contact us if you notice any discrepancies. 

SEC FIling - https://www.sec.gov/Archives/edgar/data/1620704/000147793221002683/medx_1k.htm

Thank you very much.

Med-X Team


The securities offered by Med-X, Inc. hereby are highly speculative. Investing in shares of MED-X, INC. involves significant risk. This investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that an investment could be illiquid for an indefinite period of time. No public market currently exists for the securities and if and when a public market develops following this offering it may not continue. You should read the NEW Offering Circular as well as all Securities Exchange Commission filings before making any investment in the Company. 

This release may contain forward-looking statements regarding projected business performance, operating results, financial condition and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the company incurring operating losses and experiencing unexpected material adverse events.


Topics: Med-X

Comment on this article:

+1 (818) 527-9966

Recent Posts

Posts by Tag